TABLE 1.
Baseline characteristics
| n = 175 | |
|---|---|
| Age (years | 56.0 (IQR 46.0–64.0) |
| Gender | |
| Male | 113 (64.6%) |
| Female | 62 (35.4%) |
| Ethnicity | |
| Caucasian | 146 (83.4%) |
| Asian | 16 (9.1%) |
| Black | 10 (5.7%) |
| Other | 3 (1.7%) |
| Body weight (kg) | 80.9 (IQR 69.4–92.3) |
| Height (cm) | 174.5 (IQR 166.3–182.0) |
| BMI (kg/m2) | 25.9 (IQR 23.7–29.6) |
| Primary kidney disease | |
| Diabetic nephropathy | 31 (17.7%) |
| Polycystic kidney disease | 34 (19.4%) |
| Glomerulonephritis | 8 (4.6%) |
| Hypertensive nephropathy | 30 (17.1%) |
| Reflux disease/chronic pyelonephritis | 12 (6.9%) |
| Focal segmental glomerulosclerosis | 5 (2.9%) |
| IgA nephropathy | 8 (4.6%) |
| Obstructive nephropathy | 7 (4.0%) |
| Other | 23 (13.1%) |
| Unknown | 17 (9.7%) |
| Number of kidney transplantation | |
| 1st | 162 (92.6%) |
| 2nd | 11 (6.3%) |
| 3rd | 2 (1.1%) |
| PRA% | |
| <15% | 165 (94.3%) |
| ≥15%) | 10 (5.7%) |
| Peak PRA% | |
| <15% | 147 (84.0%) |
| ≥15% | 28 (16.0%) |
| Serum creatinine (Month 3; μmol/L) | 125.0 (104.2–150.8) |
| Haematocrit (Month 3; L/L) | 0.37 (0.34–0.40) |
| Serum albumin (Month 3; g/L) | 46.0 (44.0–48.0) |
| BMI, body mass index; PRA, panel reactive antibodies. | |